Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-6bf8c574d5-9f2xs Total loading time: 0 Render date: 2025-03-04T00:29:14.194Z Has data issue: false hasContentIssue false

2 - Pathology of Lung Cancer

Published online by Cambridge University Press:  12 August 2009

By
Sabine Pomplun
Edited by
Sujal R. Desai
Sabine Pomplun
Affiliation:
Department of Histopathology, King's College Hospital, London, UK
Sujal R. Desai
Affiliation:
King's College Hospital, London
Get access

Summary

Introduction

Lung cancer remains one of the most common cancers, accounting for 12.6% of all new cancers and just under 20% of all cancer deaths. It is widely accepted that the incidence of lung cancer is closely associated with population-related smoking behaviour; the relative risk for smokers, as compared to non-smokers, is of the order of 8–15-fold for men and 3–10-fold for women dependent on factors such as the average cigarette consumption, duration of smoking, age at which the subject starts or the time since quitting, type of tobacco and the pattern of inhalation.

Traditionally, squamous cell carcinoma has the strongest association with tobacco smoking, followed by small cell carcinoma and adenocarcinoma. However, the association with adenocarcinoma has become stronger over time and this histological subtype has become the most common type in many western countries. There are also recognized occupational exposures to carcinogens known to be associated with lung cancer, the most important being asbestos, crystalline silica, radon, mixtures of polycyclic aromatic hydrocarbons and heavy metals. Welding and painting are consistently associated with an increased risk of lung cancer, but the causative agents are still unknown.

Almost all lung malignancies are carcinomas with other histological types accounting for less than 1%. In a published series on cancer incidence, small cell carcinomas comprised approximately 20% of cases and large cell carcinoma around 9%.

Type
Chapter
Information
Lung Cancer , pp. 12 - 26
Publisher: Cambridge University Press
Print publication year: 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Gilliland, F. D., Samet, J. M. (1994). Lung cancer. Cancer Surv, 19–20, 175–95.Google ScholarPubMed
Lopez-Abente, G., Pollan, M., Iglesia, P. and Ruiz, M. (1995). Characterization of the lung cancer epidemic in the European Union (1970–1990). Cancer Epidemiol Biomarkers Prev, 4, 813–20.Google Scholar
Boffetta, P., Trichopoulos, D. (2002). Cancer of the lung, larynx and pleura. In: Textbook of Cancer Epidemiology, Adami, H. O., Hunter, D., Trichopoulos, D., eds. Oxford: Oxford University Press, pp. 248–80.Google Scholar
Parkin, D. M., Whelan, S. L., Ferlay, J., Teppo, L., Thomas, D. B. (2002). Cancer incidence in Five Continents, Vol. VIII. IARC Scientific Publications No. 155. Lyon: IARC Press.Google Scholar
Feder, M., Siegfried, J. M., Balshem, A., Litwin, S., Keller, S. M., Liu, Z., Testa, J. R. (1998). Clinical relevance of chromosome abnormalities in non-small cell lung cancer. Cancer Genet Cytogenet, 102, 25–31.CrossRefGoogle ScholarPubMed
Girard, L., Zochbauer-Muller, S., Virmani, A. K., Gazdar, A. F., Minna, J. D. (2000). Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small lung cancer, and loci clustering. Cancer Res, 60, 4894–906.Google ScholarPubMed
Mao, L. (2001). Molecular abnormalities in lung carcinogenesis and their potential clinical implications. Lung Cancer, 34, Suppl 2, S27–S34.CrossRefGoogle ScholarPubMed
Minna, J. D., Roth, J. A., Gazdar, A. F. (2002). Focus on lung cancer. Cancer Cell, 1, 49–52.CrossRefGoogle ScholarPubMed
Yokota, J., Kohno, T. (2004). Molecular footprints of human lung cancer progression. Cancer Sci, 95, 17–204.CrossRefGoogle ScholarPubMed
Toyooka, S., Maruyama, R., Toyooka, K. O., McLerran, D., Feng, Z., Fukuyama, Y., Virmani, A. K., Zochbauer-Muller, S., Tsukuda, K., Sugio, K., Shimizu, N., Shimizu, K., Lee, H., Chen, C. Y., Fong, K. M., Gilcrease, M., Roth, J. A., Minna, J. D., Gazdar, A. F. (2003). Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer. Int J Cancer, 103, 153–60.Google Scholar
Franklin, W. A., Veve, R., Hirsch, F. R., Helfrich, B. A., Bunn, P. A. Jr (2002). Epidermal growth factor receptor family in lung cancer and premalignancy. Semin Oncol, 29, 3–14.CrossRefGoogle ScholarPubMed
Hirsch, F. R., Franklin, W. A., Gazdar, A. F., Bunn, P. A. Jr (2001). Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin Cancer Res, 7, 5–22.Google Scholar
Wistuba, I. I., Gazdar, A. F. (2003). Characteristic genetic alterations in lung cancer. Methods Mol Med, 74, 3–28.Google ScholarPubMed
Kawakami, S., Sone, S., Takashima, S., Li, F., Yang, Z. G., Maruyama, Y., Honda, T., Hasegawa, M., Wang, J. C. (2001). Atypical adenomatous hyperplasia of the lung: correlation between high-resolution CT findings and histopathologic features. Eur Radiol, 11, 811–14.CrossRefGoogle ScholarPubMed
Kushihashi, T., Munechika, H., Ri, K., Kubota, H., Ukisu, R., Satoh, S., Motoya, H., Kurashita, Y., Soejima, K., Kadokura, M. (1994). Bronchioloalveolar adenoma of the lung: CT-pathologic correlation. Radiology, 193, 789–93.CrossRefGoogle ScholarPubMed
Chapman, A. D., Kerr, K. M. (2000). The association between atypical adenomatous hyperplasia and primary lung cancer. Br J Cancer, 83, 632–6.CrossRefGoogle ScholarPubMed
Logan, P. M., Miller, R. R., Evans, K., Muller, N. L. (1996). Bronchogenic carcinoma and coexistent bronchioloalveolar adenomas. Assessment of radiologic detection and follow-up in 28 patients. Chest, 109, 713–17.CrossRefGoogle ScholarPubMed
Suzuki, K., Nagai, K., Yoshida, J., Yokose, T., Kodama, T., Takahashi, K., Nishimura, M., Kawasaki, H., Yokozaki, M., Nishiwaki, Y. (1997). The prognosis of resected lung carcinoma associated with atypical adenomatous hyperplasia: a comparison of the prognosis of well-differentiated adenocarcinoma associated with atypical adenomatous hyperplasia and intrapulmonary metastasis. Cancer, 79, 1521–6.3.0.CO;2-#>CrossRefGoogle ScholarPubMed
Takigawa, N., Segawa, Y., Nakata, M., Saeki, H., Mandai, K., Kishino, D., Shimono, M., Ida, M., Eguchi, K. (1999). Clinical investigation of atypical adenomatous hyperplasia of the lung. Lung Cancer, 25, 115–21.CrossRefGoogle ScholarPubMed
Aguayo, S. M., Miller, Y. E., Waldron, J. A. Jr, Bogin, R. M., Sunday, M. E., Staton, G. W. Jr, Beam, W. R., King, T. E. Jr (1992). Brief report: idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease. N Engl J Med, 327, 1285–8.CrossRefGoogle ScholarPubMed
Travis, W. D., Colby, T. V., Corrin, B., Shimosato, Y., Brambilla, E. (1999). WHO Histological classification of Tumours. Histological Typing of Lung and Pleural Tumours. 3rd ed. Berlin: Springer-Verlag.CrossRefGoogle Scholar
Roggli, V. L., Vollmer, R. T., Greenberg, S. D., McGavran, M. H., Spjut, H. J., Yesner, R. (1985). Lung cancer heterogeneity. A blinded and randomized study of 100 consecutive cases. Human Pathol, 16, 569–79.CrossRefGoogle ScholarPubMed
Travis, W. D., Brambilla, E., Muller-Hermelink, H. K., Harris, C. C. (2004). WHO Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon:IARC Press.Google Scholar
Tomashefski, J. F. Jr, Connors, A. F. Jr, Rosenthal, E. S., Hsiue, I. L. (1990). Peripheral vs central squamous cell carcinoma of the lung. A comparison of clinical features, histopathology, and survival. Arch Pathol Lab Med, 114, 468–74.Google Scholar
Funai, K., Yokose, T., Ishii, G., Araki, K., Yoshida, J., Nishiwaki, Y., Ochiai, A. (2003). Clinocopathologic characteristics of peripheral squamous cell carcinoma of the lung. Am J Surg Pathol, 27, 978–84.CrossRefGoogle Scholar
Chieng, D. C., Cangiarella, J. F., Zakowski, M. F., Goswami, S., Cohen, J. M., Yee, H. T. (2001). Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine needle aspiration specimens. Cancer, 93, 330–6.CrossRefGoogle Scholar
Chu, P. G., Weiss, L. M. (2002). Expression of cytokeratin 5/6 in epithelial neoplasms: an immunohistochemical study of 509 cases. Mod Pathol, 15, 6–10.CrossRefGoogle ScholarPubMed
Fukino, S., Hayashi, E., Fukata, T., Okada, M., Okada, K., Makihara, K., Morio, S. (1998). Primary clear cell carcinoma of the lung: report of an operative case. Kyobu Geka, 51, 513–16.Google ScholarPubMed
Scarpatetti, M., Tsybrovskyy, O., Popper, H. H. (2002). Cytokeratin typing as an aid in the differential diagnosis of primary versus metastatic lung carcinomas, and comparison with normal lung. Virchows Arch, 440, 70–6.CrossRefGoogle ScholarPubMed
Cangemi, V., Volpino, P., D'Andrea, N., Puopolo, M., Fabrizi, S., Lonardo, M. T., Piat, G. (1995). Local and/or distant recurrences in T1-2/N0-1 non-small cell lung cancer. Eur J Cardiothorac Surg, 9, 473–8.CrossRefGoogle ScholarPubMed
Curran, W. J. Jr (2001). Therapy of limited stage small cell lung cancer. Cancer Treat Res, 105, 229–52.CrossRefGoogle ScholarPubMed
Nicholson, S. A., Beasley, M. B., Brambilla, E., Hasleton, P. S., Colby, T. V., Sheppard, M. N., Falk, R., Travis, W. D. (2002). Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens. Am J Surg Pathol, 26, 1184–97.CrossRefGoogle ScholarPubMed
Folpe, A. L., Gown, A. M., Lamps, L. W., Garcia, R., Dail, D. H., Zarbo, R. J., Schmidt, R. A. (1999). Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumours. Mod Pathol, 12, 5–8.Google Scholar
Kaufmann, O., Dietel, M. (2000). Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites. Histopathology, 36, 415–20.CrossRefGoogle ScholarPubMed
Shimosato, Y., Suzuki, A., Hashimoto, T., Nishiwaki, Y., Kodama, T., Yoneyama, T., Kameya, T. (1980). Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers. Am J Surg Pathol, 4, 365–73.CrossRefGoogle Scholar
Koss, M., Travis, W. D., Moran, C., Hochholzer, L. (1992). Pseudomesotheliomatous adenocarcinoma: a reappraisal. Semin Diagn Pathol, 9, 117–23.Google ScholarPubMed
Chung, C. K., Zaino, R., Stryker, J. A., O'Neill, M. Jr, DeMuth, W. E. Jr (1982). Carcinoma of the lung: evaluation of histological grade and factors influencing prognosis. Ann Thorac Surg, 33, 599–604.CrossRefGoogle ScholarPubMed
Miyoshi, T., Satoh, Y., Okumura, S., Nakagawa, K., Shirakusa, T., Tsuchiya, E., Ishikawa, Y. (2003). Early-stage lung adenocarcinomas with a micropapillary pattern, a distinct pathologic marker for a significantly poorer prognosis. Am J Surg Pathol, 27, 101–9.CrossRefGoogle Scholar
Noguchi, M., Morikawa, A., Kawasaki, M., Matsuno, Y., Yamada, T., Hirohashi, S., Kondo, H., Shimosato, Y. (1995). Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer, 75, 2844–52.3.0.CO;2-#>CrossRefGoogle ScholarPubMed
Silver, S. A., Askin, F. B. (1997). True papillary carcinoma of the lung: a distinct clinicopathologic entity. Am J Surg Pathol, 21, 43–51.CrossRefGoogle ScholarPubMed
Lyda, M. H., Weiss, L. M. (2000). Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas. Hum Pathol, 31, 980–7.CrossRefGoogle ScholarPubMed
Sturm, N., Lantuejoul, S., Laverriere, M. H., Papotti, M., Brichon, P. Y., Brambilla, C., Brambilla, E. (2001). Thyroid transcription factor 1 and cytokeratins 1, 5, 10, 14 (34betaE12) expression in basaloid and large cell neuroendocrine carcinomas of the lung. Hum Pathol, 32, 918–25.CrossRefGoogle ScholarPubMed
Pelosi, G., Pasini, F., Sonzogni, A., Maffini, F., Maisonneuve, P., Iannucci, A., Terzi, A., Manzoni, G., Bresaoloa, E., Viale, G. (2003). Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I non-small cell lung carcinoma. Cancer, 97, 2487–97.CrossRefGoogle Scholar
Gajra, A., Tatum, A. H., Newman, N., Gamble, G. P., Lichtenstein, S., Rooney, M. T., Graziano, S. L. (2002). The predictive value of neuroendocrine markers and p53 for response to chemotherapy and survival in patients with advanced non-small cell lung cancer. Lung Cancer, 36, 159–65.CrossRefGoogle ScholarPubMed
Schleusener, J. T., Tazelaar, H. D., Jung, S. H., Cha, S. S., Cera, P. J., Myers, J. L., Creagan, E. T., Goldberg, R. M., Marschke, R. F. Jr (1996). Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated non-small cell lung carcinoma. Cancer, 77, 1284–91.3.0.CO;2-I>CrossRefGoogle Scholar
Charles, J., Rossell, R., Ariza, A., Pellicer, I., Sanchez, J. J., Fernandez-Vasalo, G., Abad, A., Barnadas, A. (1993). Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer. Lung Cancer, 10, 209–19.CrossRefGoogle Scholar
Skov, B. G., Sorensen, J. B., Hirsch, F. R., Larsson, L. I., Hansen, H. H. (1991). Prognostic impact of histologic demonstration of chromogranin A and neuron specific enolase in pulmonary adenocarcinoma. Ann Oncol, 2, 350–60.CrossRefGoogle ScholarPubMed
Sudaresan, V., Reeve, J. G., Stenning, S., Stewart, S., Bleehen, N. M. (1991). Neuroendocrine differentiation and clinical behaviour in non-small cell lung tumours. Br J Cancer, 64, 333–8.CrossRefGoogle Scholar
Ishida, T., Kaneko, S., Yokoyama, H., Inoue, T., Sugio, K., Sugimachi, K. (1992). Adenosquamous carcinoma of the lung. Clinicopathologic and immunohistochemical features. Am J Clin Pathol, 97, 678–85.CrossRefGoogle ScholarPubMed
Guarino, M., Micheli, P., Pallotti, F., Giordano, F. (1999). Pathological relevance of epithelial and mesenchymal phenotype plasticity. Pathol Res Pract, 195, 379–89.CrossRefGoogle ScholarPubMed
Colby, T. V., Koss, M., Travis, W. D. (1995). Tumors of the lower respiratory tract. 3rd ed. Washington, DC: Armed Forces Institute of Pathology.
Beasley, M. B., Thunnissen, F. B., Brambilla, E., Hasleton, P., Steele, R., Hammar, S. P., Colby, T. V., Sheppard, M. N., Shimosato, Y., Koss, M. N., Falk, R., Travis, W. D. (2000). Pulmonary atypical carcinoid: Predictors of survival in 106 cases. Hum Pathol, 31, 1250–65.CrossRefGoogle ScholarPubMed
Fink, G., Krelbaum, T., Yellin, A., Bendayan, D., Saute, M., Glazer, M., Kramer, M. R. (2001). Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 patients in Israel and review of 640 cases from the literature. Chest, 119, 1647–51.CrossRefGoogle ScholarPubMed
Thomas, C. F. Jr, Tazelaar, H. D., Jett, J. R. (2001). Typical and atypical pulmonary carcinoids: outcome in patients presenting with regional lymph node involvement. Chest, 119, 1143–50.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×